The book investigates the design, execution, and interpretation of randomized clinical trials in the field of cancer research. It addresses the critical need for rigorous methodologies to evaluate new cancer treatments, focusing on the statistical principles and ethical considerations that underpin such studies. The work aims to provide a comprehensive overview for researchers and clinicians involved in developing and implementing cancer therapies.

This text is likely to be regarded as a foundational work for researchers and clinicians engaged in oncology. Its focus on the methodological rigor of randomized trials suggests it serves as a key resource for understanding evidence-based cancer treatment evaluation. The book's detailed approach to design, statistics, and ethics would appeal to those seeking to advance or critically assess cancer research protocols.